Trial intelligence / Profile preview

Linaclotide vs macrogol 4000 powder for functional constipation

ChiCTR2300069934Phase 4Completed

Sponsor
Chengdu Hospital of Integrated Traditional Chinese and Western Medicine
Start
Mar 2023
Modality
Peptides
Countries
1
01

Overview

Phase 4, open-label trial of linaclotide in functional constipation (FC) (2 arms), sponsored by Chengdu Hospital of Integrated Traditional Chinese and Western Medicine. Primary endpoint: complete spontaneous bowel movement. Started Mar 2023; status: completed.

02

Drugs

linaclotide
03

Conditions

functional constipation (FC)

Beyond the preview

Go deeper on ChiCTR2300069934.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300069934.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call